Jiangsu Hualan New Pharmaceutical Material Co. Ltd.

301093 · SHE · Healthcare / Medical Instruments & Supplies

48.50CNY-1.60 (-3.19%)

Price History

Full chart

Market Stats

Previous Close50.10

Open48.90

Day Range48.30 – 50.92

52-Week Range26.06 – 110.25

Volume3.32M

Market Cap13.45B

P/E (TTM)525.92

Forward P/E0.00

EPS0.12

Dividend Yield0.08%

Beta0.93

50-Day Avg68.46

200-Day Avg69.50

About

Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. engages in the research and development, manufacture, and sale of packaging materials for the injectable pharmaceuticals in China and internationally. It offers laminated and conventional rubber stoppers; halogenated butyl polytetrafluoroethylene film rubber stoppers and halogenated butyl polyester film rubber stoppers; and rubber components for pen syringes (cassette vials), assemblies for plastic infusion containers, silicone rubber products, medical devices and accessories, etc. Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. was founded in 1992 and is based in Jiangyin, China.

Company Details

SectorHealthcare
IndustryMedical Instruments & Supplies
CEOMr. Yimin Hua
Employees945
HeadquartersNo. 1488, Chenglu, Jiangyin, China, 214443, China
Websitehttps://www.hua-lan.com

Leadership

Mr. Yimin HuaGM & Chairman · b. 1982
Mr. Lizhong XuFinancial Director & Deputy GM · b. 1973
Mr. Feng XiaoDeputy GM & Director · b. 1963
Ms. Xue LiuDeputy GM & Secretary of the Board · b. 1995
Mr. Zhimin HuaDeputy General Manager · b. 1989
Mr. Wuping WangAccounting Supervisor

Financials

Income Statement

Currency: CNY	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	459.75M	446.32M	820.87M	584.14M	622.92M	586.41M	619.45M
Growth (%)	-	-2.92%	+83.92%	-28.84%	+6.64%	-5.86%	+5.63%
Cost of Revenue	221.70M	237.12M	368.39M	329.29M	363.63M	358.97M	378.66M
Gross Profit	238.05M	209.21M	452.47M	254.85M	259.29M	227.44M	240.79M
Gross Margin	51.78%	46.87%	55.12%	43.63%	41.62%	38.79%	38.87%
Operating Expense	113.29M	104.16M	191.41M	181.22M	173.36M	186.84M	183.31M
Operating Income	124.76M	105.05M	261.07M	73.63M	85.93M	40.60M	57.49M
Operating Margin	27.14%	23.54%	31.80%	12.61%	13.80%	6.92%	9.28%
EBITDA	214.91M	128.42M	285.96M	145.13M	182.16M	115.25M	138.29M
EBITDA Margin	46.75%	28.77%	34.84%	24.85%	29.24%	19.65%	22.32%
Net Income	95.17M	81.36M	216.02M	93.75M	117.93M	49.57M	60.18M
Net Income Margin	20.70%	18.23%	26.32%	16.05%	18.93%	8.45%	9.71%
R&D	19.83M	23.66M	42.08M	36.69M	36.18M	39.54M	39.51M
R&D as % of Total Revenue	4.31%	5.30%	5.13%	6.28%	5.81%	6.74%	6.38%
Interest Expense	55.16M	6.80M	4.83M	599.38K	439.26K	249.27K	1.35M
Interest Expense % of Total Revenue	12.00%	1.52%	0.59%	0.10%	0.07%	0.04%	0.22%

Balance Sheet

Currency: CNY	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	597.50M	621.62M	2.63B	2.58B	2.71B	2.50B	2.55B
Total Liabilities	237.02M	225.23M	216.51M	164.21M	225.40M	255.99M	355.47M
Total Equity	360.48M	396.39M	2.42B	2.42B	2.49B	2.25B	2.19B
Cash	48.27M	58.47M	1.87B	145.51M	421.55M	399.65M	354.16M
Net Debt	92.92M	66.12M	-	-	-	-	-

Cash Flow

Currency: CNY	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	92.09M	133.40M	216.54M	94.88M	223.85M	120.78M	115.49M
Capital Expenditure	29.81M	39.54M	123.76M	173.62M	297.25M	135.43M	132.59M
Free Cash Flow	62.28M	93.86M	92.78M	-78.73M	-73.39M	-14.65M	-17.09M
Dividends Paid	53.31M	52.01M	4.47M	94.90M	40.93M	77.65M	26.19M
FCF to OCF	67.63%	70.36%	42.85%	-82.98%	-32.79%	-12.13%	-14.80%
Dividend Paid to FCF	85.59%	55.41%	4.81%	-120.53%	-55.77%	-530.11%	-153.21%

Earnings

Report Date	Mar 31, 2022	Jun 30, 2022	Sep 30, 2022	Dec 31, 2022	Mar 31, 2023	Aug 28, 2023	Oct 22, 2023	Dec 31, 2023	Apr 25, 2024	Jun 30, 2024	Oct 24, 2024	Dec 31, 2024	Apr 20, 2025	Jun 30, 2025	Sep 30, 2025	Dec 31, 2025	Mar 31, 2026	Jun 30, 2026
EPS Estimate	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS Actual	0.14	0.11	0.09	0.08	0.15	0.20	0.22	0.13	0.08	0.12	0.12	-0.01	0.15	0.12	0.05	0.03	0.00	0.03
Surprise	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Timing	-	-	-	-	-	After-hours	Pre-market	-	Pre-market	-	Pre-market	-	Pre-market	-	-	-	-	-

Key Statistics & Ratios

Market Cap13.45B

Enterprise Value14.73B

Trailing P/E525.92

Forward P/E0.00

Price / Sales22.10

Price / Book7.24

EPS0.12

Book Value10.25

Revenue (TTM)608.73M

Gross Profit (TTM)233.08M

EBITDA87.26M

Profit Margin3.96%

Operating Margin1.59%

Return on Equity1.05%

Return on Assets0.29%

Shares Outstanding213.13M

Shares Float143.40M

Beta0.93

Dividend Yield0.08%

Dividend Rate0.05

Payout Ratio43.48%

Dividends

20261×

0.05Jul 16, 2026

20251×

0.12Jul 14, 2025

20241×

0.36Jun 28, 2024

20231×

0.18Jul 6, 2023

20221×

0.41Jun 7, 2022

Stock Splits

Jul 16, 20261.3:1
Jul 14, 20251.3:1